Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale Chief Financial Officer sold 1,428 shares at $11.22 ($16,022)
  2. 4 Open-market sale President and CEO sold 3,195 shares at $11.22 ($35,848)
  3. 4 Grant or award EVP, Head of R&D acquired 46,250 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award SVP, GC & Secretary acquired 55,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Operations Officer sold 657 shares at $7.94 ($5,217)
  12. 4 Open-market sale Chief Financial Officer sold 1,827 shares at $9.17 ($16,754)
  13. 4 Open-market sale Chief Operations Officer sold 2,740 shares at $9.17 ($25,126)
  14. 4 Grant or award Chief Financial Officer acquired 66,875 shares (grant or award)
  15. 4 Grant or award Chief Commercial Officer acquired 55,000 shares (grant or award)
  16. 4 Grant or award Chief Operations Officer acquired 75,000 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale Chief Tech. Operations Officer sold 4,117 shares at $14.21 ($58,503)

Page 12 of 33 · 645 filings